Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
Clinical trial NCT02593331 · COMPLETED
Trial details
- NCT number
- NCT02593331
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-29
- Primary completion
- 2017-03-28
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.